| EPA0040 | Ibalizumab and CD4 domain 2 exert an allosteric effect on HIV envelope binding to CD4 domain1 | E-poster | Host immune responses, vaccines and immunotherapies |
| EPA0041 | Effect on time of SIVmac251 acquisition by passive administration of monoclonal antibodies recognizing SIV V2 in either the CH59-like coil/helical or the b-sheet conformations | E-poster | Host immune responses, vaccines and immunotherapies |
| EPA0042 | Identification and characterization of HIV-1-specific CD8+ T cells in highly HIV-1 exposed but uninfected MsM in Vietnam | E-poster | Host immune responses, vaccines and immunotherapies |
| EPA0043 | Favourable transcriptomic signature of HIV-specific CD8 T cells in response to single anti-PD1 dose in people with HIV on ART and cancer | E-poster | Host immune responses, vaccines and immunotherapies |
| EPA0044 | CX3CR1+ macrophages as guardians of the intestinal barrier: lessons learnt from non-human primates exposed to SIV or SARS CoV-2 | E-poster | Host immune responses, vaccines and immunotherapies |
| EPA0045 | Longitudinal humoral and celular immune responses to mRNA SARS-CoV-2 vaccination in adolescents living with HIV | E-poster | Host immune responses, vaccines and immunotherapies |
| EPA0046 | Immunogenicity of conjugate meningococcal ACWY-TT vaccine in adolescents living with HIV | E-poster | Host immune responses, vaccines and immunotherapies |
| EPA0047 | Cryo-EM analysis provide structural insights for broad HIV-1 neutralization by a heavy chain matured antibody from an Indian pediatric elite-neutralizer | E-poster | Host immune responses, vaccines and immunotherapies |
| EPA0048 | Feasibility of iNKT cells as an immunotherapeutic HIV cure intervention | E-poster | Host immune responses, vaccines and immunotherapies |
| EPA0049 | HIV vaccine candidate efficacy mediated by epigenetic changes in CD14+ cells and cAMP-dependent efferocytosis | E-poster | Host immune responses, vaccines and immunotherapies |